about
Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalisNF-kappaB activation is required for apoptosis in fibrocystin/polyductin-depleted kidney epithelial cellsRelease of sICAM-1 in oocytes and in vitro fertilized human embryosDocking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expressionVirtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.Virtual screening against nuclear factor κB (NF-κB) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-κB dependent biological functions involved in cystic fibrosis.Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines.Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-kappaB.The loss of cellular junctions in epithelial lung cells induced by cigarette smoke is attenuated by corilaginIncrease of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules.Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives.Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development.miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Involvement of miRNA in erythroid differentiation.Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity.Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functionsInteraction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells.gamma-Hydroxymethyl PNAs: Synthesis, interaction with DNA and inhibition of protein/DNA interactions.Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors.Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin.Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance.Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cellsAntibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses.Expression of pro-inflammatory interleukin-8 is reduced by ayurvedic decoctions.Effect of atrial natriuretic peptide on reactive oxygen species-induced by hydrogen peroxide in THP-1 monocytes: role in cell growth, migration and cytokine release.Lysis-on-chip of single target cells following forced interaction with CTLs or NK cells on a dielectrophoresis-based array.Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells.Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.In vitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells.Antioxidant and antiproliferative activity of Laurus nobilis L. (Lauraceae) leaves and seeds essential oils against K562 human chronic myelogenous leukaemia cells.Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).
P50
Q21254649-FCF33BA3-D73E-410B-B8ED-45D404A677EBQ24322071-630469C5-8E7B-460E-A8BB-144F39BA571AQ28474343-C16E7D14-AC2B-4287-AC9B-73168542A3B5Q33366140-8DD82C5A-A620-4D1A-849D-36ACC60B48A4Q33508859-216D2929-2E1E-42DE-B5BA-E3082F410171Q33729936-E686E64B-80A8-4EC6-8EB1-8D72DB203D39Q33874258-D311640E-40BC-453A-8E16-49D2633E3BE6Q34611393-37740D05-8A3C-4AE5-AFA3-2124DB0CBAD4Q35162508-991B77C6-BF0B-453D-8669-650BDF564C30Q35301892-2B5AE33C-ACEF-4456-8680-A1C96F59AB49Q36290290-109CBADF-1001-4E45-A26C-9A4E7239963EQ36611332-4F1E7FCC-22EB-4732-9357-8C00B2BE5144Q36753123-511378C2-F1B5-4787-9DF7-DFFAB2646B2FQ37309900-A999444C-07FD-45FC-BCD7-0422E6F0E668Q37590391-D66C36B0-F92D-42D9-A821-41FBA9B12C52Q37921863-6D87E169-2BF6-4962-84CC-0B66A97745C1Q37962609-43CCD34C-67A4-4EE0-8CCF-4A0C15EF2E1DQ37983889-A554503F-41D1-4B6B-84AC-E2C4B023F218Q38294247-1492E0FF-D4D5-4F7E-829E-4A28F6A38767Q38297602-3A81AE90-50A9-43D7-9012-BE3728F5EA4DQ38302444-8D562E47-A7AB-4085-A284-D50BE5230765Q38318715-8063E65A-E506-4F2B-B247-0D240F5407BBQ38321556-588D4F97-4DC7-47D3-B8D4-151900664F38Q38342349-42734F27-0E31-4F03-9D75-5A0F5D15F7FFQ38360640-D5EFD3CF-1E5B-49A2-BA53-1EF0C7913064Q38363753-5C26FE45-B131-4B4D-A293-4F966EF0A80BQ38907520-2F7997EB-C095-4001-9099-C858C703A422Q38911516-8D842FA3-8D5B-4EC2-AF12-A06C1DA2EDEEQ38939602-BA9C58B3-1C58-41C0-B3E1-6BA9195743F1Q38958442-DC8C3775-0B6F-4AFE-8B8C-C8202792F584Q39018554-58EB6211-9521-43FA-8B4F-EC9195A69B1EQ39033925-94D440EF-46EC-440E-B6AE-C854C8C1BE67Q39036966-12DD2583-B4CC-4A93-A2E3-A26C372E0CF6Q39080108-940BD844-29D8-4E97-8DA9-6280D73C7457Q39100054-D92D0F62-3FE6-4BA3-ABEA-5E7D25A5A4ABQ39353313-3541E0DC-3724-4D63-A8DB-3FA2DCB2DEF5Q39388051-93D0F7D9-4D69-4BBD-BE0B-F8CB159A5614Q39428800-BA246D4F-CDE3-4416-8CF5-B990AC27D49CQ39454834-5ECA2EE9-2756-4242-9AD1-487DAE73890DQ39455677-9EBD1E27-ECE8-4078-B17E-A4D7EACD9947
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Monica Borgatti
@ast
Monica Borgatti
@en
Monica Borgatti
@es
Monica Borgatti
@nl
Monica Borgatti
@sl
type
label
Monica Borgatti
@ast
Monica Borgatti
@en
Monica Borgatti
@es
Monica Borgatti
@nl
Monica Borgatti
@sl
prefLabel
Monica Borgatti
@ast
Monica Borgatti
@en
Monica Borgatti
@es
Monica Borgatti
@nl
Monica Borgatti
@sl
P1053
G-2611-2015
P106
P1153
7003682206
P2038
Monica_Borgatti
P21
P31
P3829
P496
0000-0001-8470-2496